论文信息 - The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain. - 字舞流文

The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain.

P. Mantyh | J. Ghilardi | M. Sabino | M. Schwei | C. Peters | S. Rogers | J. Jongen | N. M. Luger | K. Feia | C. P. Keyser | D. B. Mach | C. De Filipe | J. R. Ghilardi

[1] P. Mantyh,et al. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. , 2002, Cancer research.

[2] R. Coleman. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. , 2001, Cancer treatment reviews.

[3] P. Mantyh,et al. Osteoprotegerin diminishes advanced bone cancer pain. , 2001, Cancer research.

[4] Adam Sapirstein,et al. Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity , 2001, Nature.

[5] P. Mantyh,et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord , 2000, Nature Medicine.

[6] T. Dimpfl,et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[7] P. Mantyh,et al. Neurochemical and Cellular Reorganization of the Spinal Cord in a Murine Model of Bone Cancer Pain , 1999, The Journal of Neuroscience.

[8] Paul Jacobsen,et al. Breakthrough pain: characteristics and impact in patients with cancer pain , 1999, Pain.

[9] R. Payne,et al. Mechanisms and management of bone pain , 1997, Cancer.

[10] S. Mercadante. Malignant bone pain: pathophysiology and treatment , 1996, Pain.

[11] P. Boyle,et al. Pathophysiology and Treatment , 2000 .